Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) reported upbeat second-quarter earnings and 2025 guidance on Thursday. The company ...

CyberArk Software Ltd. (NASDAQ:CYBR) is one of the 10 AI Stocks Investors Should Keep an Eye On. On July 30, William Blair ...

Lenz Therapeutics has earned the FDA’s go-ahead for its aceclidine eye drop to crack the large presbyopia market, where past ...

In CCC v AAC [2025] HKCFI 2987, Sir William Blair, sitting as Deputy High Court Judge in the Hong Kong Court of First Instance (“Court”), rejected ...

Despite the overall decline in commercial product revenue, Moderna was also pleasantly surprised by Q2 Spikevax sales, which ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

Avantor missed Q2 EPS expectations as weak bioprocessing sales and customer disruptions pressured earnings, despite flat organic growth and a CEO change.

We continue to feel confident about our ability to capture 90%," LPL CEO Rich Steinmeier told analysts during the firm's 2nd ...

Enovix's Q2 2025 earnings call highlights record revenue growth, A1 platform launch, and commercialization strides.

CFO Anil Kumar Doradla reported, "We recorded the second quarter revenue of $101.1 million, slightly higher than the midpoint of our $100 million to $102 million guidance." He added, "Non-GAAP EBITDA ...

Mastercard eased concerns about a potential slowdown in consumer spending after beating Wall Street estimates for ...

Global stocks weakened on Friday morning after US President Donald Trump hit multiple countries with a blitz of tariffs.